Martin J. Edelman, MD
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Chair, Department of Hematology/Oncology
Professor, Department of Hematology/Oncology
Deputy Cancer Center Director for Clinical Research
Specialties
Research Program
Key Awards
 |
| Medical Oncology |
Chair, Department of Hematology/Oncology
Dr. Edelman collaborates with our clinical, scientific, and administrative leadership to grow robust therapeutic, clinical research, and translational research programs in hematology and medical oncology while leading the department in evaluating emerging national trends in the delivery of care to cancer patients. In addition, Dr. Edelman is Deputy Cancer Center Director for Clinical Research, assisting a strong investigator-initiated clinical trials program.
A nationally recognized expert in the treatment and research of lung cancer, Dr. Edelman developed one of the most commonly used regimens for treating advanced lung cancer and has focused on the development of new agents and biomarkers to personalize lung cancer therapy. He has a particular interest in approaches that integrate surgery, radiation, and chemotherapy in the management of lung cancer patients.
Dr. Edelman serves on the Lung Cancer Committee of the Alliance (previously CALGB), the Board of Directors of the Alliance for Clinical Trials in Oncology, and the Thoracic Malignancies Steering Committee of the National Cancer Institute’s Scientific Review Group. In addition, he is the Medical Oncology Co-chair for the Lung Cancer Committee of the Radiation Therapy Oncology Group (RTOG) and is an active member and past chair of the Career Development and Ethics Committees of the International Association for the Study of Lung Cancer (IASLC).
Dr. Edelman has published more than 325 scientific articles, abstracts, and book chapters. In addition, he has served on the editorial boards or as an ad-hoc reviewer of numerous academic journals, including the New England Journal of Medicine and the Journal of Clinical Oncology, and currently serves as Associate Editor of the journal Lung Cancer.
Educational Background
- Postdoctoral Scholar, University of California, San Diego, CA 1990
- Fellowship, Hematology/Oncology, Naval Hospital, San Diego, CA 1990
- Residency, Internal Medicine, Naval Hospital, San Diego, CA, 1986
- Internship, Internal Medicine, Naval Hospital, San Diego, CA, 1983
- MD, The Albany Medical College, Albany, NY, 1982
- BS, Biology (cum laude), Rensselaer Polytechnic Institute, Troy, NY, 1982
Certifications
- American Board of Internal Medicine, subspecialty certificate in Hematology 1990
- American Board of Internal Medicine, subspecialty in Medical Oncology 1989
- American Board of Internal Medicine 1986
- National Board of Medical Examiners 1983
Memberships
- American Society for Clinical Oncology
- European Society of Medical Oncology
- International Association for the Study of Lung Cancer
- Thoracic Malignancies Steering Committee of the National Cancer Institute
- Lung Cancer Committee of the Radiation Therapy Oncology Group (RTOG, NRG): Medical Oncology Co-Chair
Honors & Awards
- Philadelphia Magazine Top Doctors, 2018-21
- America's Top Doctors®, 2017
- Fellow, American College of Physicians 2011
- Teaching Award, Department of Medicine, University of Maryland 2010
- Award from Undersecretary of VA for Health Affairs 1998
Research Program
Research Interests
Thoracic oncology malignancies; lung metastases
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Chair, Department of Hematology/Oncology
Professor, Department of Hematology/Oncology
Deputy Cancer Center Director for Clinical Research
Specialties
Research Program
Key Awards
|
| Medical Oncology |
Chair, Department of Hematology/Oncology
Dr. Edelman collaborates with our clinical, scientific, and administrative leadership to grow robust therapeutic, clinical research, and translational research programs in hematology and medical oncology while leading the department in evaluating emerging national trends in the delivery of care to cancer patients. In addition, Dr. Edelman is Deputy Cancer Center Director for Clinical Research, assisting a strong investigator-initiated clinical trials program.
A nationally recognized expert in the treatment and research of lung cancer, Dr. Edelman developed one of the most commonly used regimens for treating advanced lung cancer and has focused on the development of new agents and biomarkers to personalize lung cancer therapy. He has a particular interest in approaches that integrate surgery, radiation, and chemotherapy in the management of lung cancer patients.
Dr. Edelman serves on the Lung Cancer Committee of the Alliance (previously CALGB), the Board of Directors of the Alliance for Clinical Trials in Oncology, and the Thoracic Malignancies Steering Committee of the National Cancer Institute’s Scientific Review Group. In addition, he is the Medical Oncology Co-chair for the Lung Cancer Committee of the Radiation Therapy Oncology Group (RTOG) and is an active member and past chair of the Career Development and Ethics Committees of the International Association for the Study of Lung Cancer (IASLC).
Dr. Edelman has published more than 325 scientific articles, abstracts, and book chapters. In addition, he has served on the editorial boards or as an ad-hoc reviewer of numerous academic journals, including the New England Journal of Medicine and the Journal of Clinical Oncology, and currently serves as Associate Editor of the journal Lung Cancer.
Education
Educational Background
- Postdoctoral Scholar, University of California, San Diego, CA 1990
- Fellowship, Hematology/Oncology, Naval Hospital, San Diego, CA 1990
- Residency, Internal Medicine, Naval Hospital, San Diego, CA, 1986
- Internship, Internal Medicine, Naval Hospital, San Diego, CA, 1983
- MD, The Albany Medical College, Albany, NY, 1982
- BS, Biology (cum laude), Rensselaer Polytechnic Institute, Troy, NY, 1982
Certifications
- American Board of Internal Medicine, subspecialty certificate in Hematology 1990
- American Board of Internal Medicine, subspecialty in Medical Oncology 1989
- American Board of Internal Medicine 1986
- National Board of Medical Examiners 1983
Memberships
- American Society for Clinical Oncology
- European Society of Medical Oncology
- International Association for the Study of Lung Cancer
- Thoracic Malignancies Steering Committee of the National Cancer Institute
- Lung Cancer Committee of the Radiation Therapy Oncology Group (RTOG, NRG): Medical Oncology Co-Chair
Honors & Awards
- Philadelphia Magazine Top Doctors, 2018-21
- America's Top Doctors®, 2017
- Fellow, American College of Physicians 2011
- Teaching Award, Department of Medicine, University of Maryland 2010
- Award from Undersecretary of VA for Health Affairs 1998
Research Profile
Research Interests
Thoracic oncology malignancies; lung metastases
Related Articles
10 PATIENT COMMENTS
-
5.0
June 25, 2022
I was impressed w/the professionalism & organization of each person & experience.
-
5.0
June 24, 2022
Can't say enough good things about this hospital & drs. & staff.
-
5.0
April 27, 2022
Excellent care given [...]
-
5.0
April 15, 2022
We had a very good experience.
-
5.0
October 02, 2021
Excellent treatment over the last 15 months since the inception of my [...]
-
5.0
August 20, 2021
Very good experience.
-
5.0
July 29, 2021
Everybody that works here is great .Dr. Edelman is excellent. [...], his nurse is fabulous. [...] the receptionist Is super personable
-
5.0
June 01, 2021
Dr. Edelman really has been wonderful throughout my many years of treatment. I am very appreciated.
-
5.0
May 25, 2021
Excellent.
-
5.0
March 22, 2021
Very happy with my provider.
LOAD MORE